• 四川大學(xué)華西醫(yī)院普外科（成都 610041）;

引用本文： 李月春,伍曉汀. 胃癌病理學(xué)與生物學(xué)特征的關(guān)系. 中國(guó)普外基礎(chǔ)與臨床雜志, 2006, 13(1): 120-122. doi: 復(fù)制

版權(quán)信息： ?四川大學(xué)華西醫(yī)院華西期刊社《中國(guó)普外基礎(chǔ)與臨床雜志》版權(quán)所有，未經(jīng)授權(quán)不得轉(zhuǎn)載、改編

1. Henson DE, Dittus C, Younes M, et al. Differential trends in the intestinal and diffuse types of gastric carcinoma in the United States, 1973-2000: increase in the signet ring cell type [J]. Arch Pathol Lab Med, 2004; 128(7)∶765.
2. Wang Y, Song JP, Ikeda M, et al. IleLeu substitution (I415L) in germline Ecadherin gene (CDH1) in Japanese familial gastric cancer [J]. Jpn J Clin Oncol, 2003; 33(1)∶17.
3. BrooksWilson AR, Kaurah P, Suriano G, et al. Germline Ecadherin mutations in hereditary diffuse gastric cancer: assessment of 42 new families and review of genetic screening criteria [J]. J Med Genet, 2004; 41(7)∶508.
4. Flucke U, Monig SP, Baldus SE, et al. Differences between biopsyor specimenrelated Lauren and World Health Organization classification in gastric cancer [J]. World J Surg, 2002; 26(2)∶ 137.
5. Mihailovici MS, Danciu M, Teleman S, et al. Diagnosis of gastric cancer on endobiopsies using the WHO classification [J]. Rev Med Chir Soc Med Nat Iasi， 2002; 106(4)∶725.
6. Rindi G, Bordi C, Rappel S, et al. Gastric carcinoids and neuroendocrine carcinomas: pathogenesis, pathology, and behavior [J]. World J Surg, 1996; 20(2)∶168.
7. Rugge M, Correa P, Dixon MF, et al. Gastric dysplasia: the Padova international classification [J]. Am J Surg Pathol, 2000; 24(2)∶167.
8. Japanese Gastric Cancer Association. Japanese classification of gastric carcinoma——2nd English Edition [J]. Gastric Cancer， 1998； 1(1)∶ 10.
9. Goseki N, Takizawa T, Koike M. Differences in the mode of the extension of gastric cancer classified by histological type: new histological classification of gastric carcinoma [J]. Gut, 1992； 33(5)∶ 606.
10. Songun I, vandeVelde CJ, Arends JW, et al. Classification of gastric carcinoma using the Goseki system provides prognostic information additional to TNM staging [J]. Cancer, 1999; 85(10)∶ 2114.
11. Guglielmi A, de Manzoni G, Tomezzoli A, et al. Prognostic value of histologic classifications of advanced stomach cancer: comparative study of Lauren’s and Goseki’s classifications [J]. Chir Ital, 1997; 49(3)∶ 45.
12. Monig S, Baldus SE, Collet PH, et al.Histological grading in gastric cancer by Goseki classification: correlation with histopathological subtypes and prognosis [J]. Anticancer Res, 2001; 21(1B)∶ 617.
13. Ming SC. Gastric carcinoma. A pathobiological classification [J]. Cancer, 1977; 39(7)∶ 2475.
14. Roukos DH, Lorenz M, Karakostas K, et al. Pathological serosa and nodebased classification accurately predicts gastric cancer recurrence risk and outcome, and determines potential and limitation of a Japanesestyle extensive surgery for Western patients: a prospective with quality control 10year followup study [J].Br J Cancer, 2001; 84(12)∶1602.
15. Han HS, Kim HS, Woo DK, et al. Loss of heterozygosity in gastric neuroendocrine tumor [J]. Anticancer Res, 2000; 20(5A)∶2849.
16. Koo SH, Jeong TE, Kang J, et al. Prognostic implications for gastric carcinoma based on loss of heterozygosity genotypes correlation with clinicopathologic variables [J]. Cancer Genet Cytogenet, 2004; 153(1)∶26.
17. Lee HS, Choi SI, Lee HK, et al. Distinct clinical features and outcomes of gastric cancers with microsatellite instability [J]. Mod Pathol, 2002; 15(3)∶ 632.
18. Wang JY, Hsieh JS, Chen CC, et al. Alterations of APC, cmet, and p53 genes in tumor tissue and serum of patients with gastric cancers[J]. J Surg Res, 2004; 120(4)∶ 242.
19. Kuraoka K, Matsumura S, Hamai Y, et al. A single nucleotide polymorphism in the transmembrane domain coding region of HER2 is associated with development and malignant phenotype of gastric cancer [J]. Int J Cancer, 2003; 107(4)∶593.
20. Migliavacca M, Ottini L, Bazan V, et al. TP53 in gastric cancer: mutations in the l3 loop and LSH motif DNAbinding domains of TP53 predict poor outcome [J]. J Cell Physiol, 2004; 200(3)∶476.
21. Lee JH, Abraham SC, Kim HS, et al. Inverse relationship between APC gene mutation in gastric adenomas and development of adenocarcinoma[J]. Am J Pathol, 2002; 161(2)∶ 611.
22. Rocco A, Schandl L, Chen J, et al. Loss of FHIT protein expression correlates with disease progression and poor differentiation in gastric cancer[J]. J Cancer Res Clin Oncol, 2003; 129(2)∶84.
23. Fang DC, Luo YH, Yang SM, et al. Mutation analysis of APC gene in gastric cancer with microsatellite instability [J]. World J Gastroenterol, 2002; 8(5)∶787.
24. Oertli D, Herzog U, Tondelli P. Prognostic factors in resected stomach carcinoma [J].Schweiz Med Wochenschr, 1994; 124(22)∶ 945.
  1. 1. Henson DE, Dittus C, Younes M, et al. Differential trends in the intestinal and diffuse types of gastric carcinoma in the United States, 1973-2000: increase in the signet ring cell type [J]. Arch Pathol Lab Med, 2004; 128(7)∶765.
  2. 2. Wang Y, Song JP, Ikeda M, et al. IleLeu substitution (I415L) in germline Ecadherin gene (CDH1) in Japanese familial gastric cancer [J]. Jpn J Clin Oncol, 2003; 33(1)∶17.
  3. 3. BrooksWilson AR, Kaurah P, Suriano G, et al. Germline Ecadherin mutations in hereditary diffuse gastric cancer: assessment of 42 new families and review of genetic screening criteria [J]. J Med Genet, 2004; 41(7)∶508.
  4. 4. Flucke U, Monig SP, Baldus SE, et al. Differences between biopsyor specimenrelated Lauren and World Health Organization classification in gastric cancer [J]. World J Surg, 2002; 26(2)∶ 137.
  5. 5. Mihailovici MS, Danciu M, Teleman S, et al. Diagnosis of gastric cancer on endobiopsies using the WHO classification [J]. Rev Med Chir Soc Med Nat Iasi， 2002; 106(4)∶725.
  6. 6. Rindi G, Bordi C, Rappel S, et al. Gastric carcinoids and neuroendocrine carcinomas: pathogenesis, pathology, and behavior [J]. World J Surg, 1996; 20(2)∶168.
  7. 7. Rugge M, Correa P, Dixon MF, et al. Gastric dysplasia: the Padova international classification [J]. Am J Surg Pathol, 2000; 24(2)∶167.
  8. 8. Japanese Gastric Cancer Association. Japanese classification of gastric carcinoma——2nd English Edition [J]. Gastric Cancer， 1998； 1(1)∶ 10.
  9. 9. Goseki N, Takizawa T, Koike M. Differences in the mode of the extension of gastric cancer classified by histological type: new histological classification of gastric carcinoma [J]. Gut, 1992； 33(5)∶ 606.
  10. 10. Songun I, vandeVelde CJ, Arends JW, et al. Classification of gastric carcinoma using the Goseki system provides prognostic information additional to TNM staging [J]. Cancer, 1999; 85(10)∶ 2114.
  11. 11. Guglielmi A, de Manzoni G, Tomezzoli A, et al. Prognostic value of histologic classifications of advanced stomach cancer: comparative study of Lauren’s and Goseki’s classifications [J]. Chir Ital, 1997; 49(3)∶ 45.
  12. 12. Monig S, Baldus SE, Collet PH, et al.Histological grading in gastric cancer by Goseki classification: correlation with histopathological subtypes and prognosis [J]. Anticancer Res, 2001; 21(1B)∶ 617.
  13. 13. Ming SC. Gastric carcinoma. A pathobiological classification [J]. Cancer, 1977; 39(7)∶ 2475.
  14. 14. Roukos DH, Lorenz M, Karakostas K, et al. Pathological serosa and nodebased classification accurately predicts gastric cancer recurrence risk and outcome, and determines potential and limitation of a Japanesestyle extensive surgery for Western patients: a prospective with quality control 10year followup study [J].Br J Cancer, 2001; 84(12)∶1602.
  15. 15. Han HS, Kim HS, Woo DK, et al. Loss of heterozygosity in gastric neuroendocrine tumor [J]. Anticancer Res, 2000; 20(5A)∶2849.
  16. 16. Koo SH, Jeong TE, Kang J, et al. Prognostic implications for gastric carcinoma based on loss of heterozygosity genotypes correlation with clinicopathologic variables [J]. Cancer Genet Cytogenet, 2004; 153(1)∶26.
  17. 17. Lee HS, Choi SI, Lee HK, et al. Distinct clinical features and outcomes of gastric cancers with microsatellite instability [J]. Mod Pathol, 2002; 15(3)∶ 632.
  18. 18. Wang JY, Hsieh JS, Chen CC, et al. Alterations of APC, cmet, and p53 genes in tumor tissue and serum of patients with gastric cancers[J]. J Surg Res, 2004; 120(4)∶ 242.
  19. 19. Kuraoka K, Matsumura S, Hamai Y, et al. A single nucleotide polymorphism in the transmembrane domain coding region of HER2 is associated with development and malignant phenotype of gastric cancer [J]. Int J Cancer, 2003; 107(4)∶593.
  20. 20. Migliavacca M, Ottini L, Bazan V, et al. TP53 in gastric cancer: mutations in the l3 loop and LSH motif DNAbinding domains of TP53 predict poor outcome [J]. J Cell Physiol, 2004; 200(3)∶476.
  21. 21. Lee JH, Abraham SC, Kim HS, et al. Inverse relationship between APC gene mutation in gastric adenomas and development of adenocarcinoma[J]. Am J Pathol, 2002; 161(2)∶ 611.
  22. 22. Rocco A, Schandl L, Chen J, et al. Loss of FHIT protein expression correlates with disease progression and poor differentiation in gastric cancer[J]. J Cancer Res Clin Oncol, 2003; 129(2)∶84.
  23. 23. Fang DC, Luo YH, Yang SM, et al. Mutation analysis of APC gene in gastric cancer with microsatellite instability [J]. World J Gastroenterol, 2002; 8(5)∶787.
  24. 24. Oertli D, Herzog U, Tondelli P. Prognostic factors in resected stomach carcinoma [J].Schweiz Med Wochenschr, 1994; 124(22)∶ 945.